Mirae Asset Global Etfs Holdings Ltd. Castle Biosciences Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Castle Biosciences Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 13,016 shares of CSTL stock, worth $439,680. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,016Holding current value
$439,680% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CSTL
# of Institutions
177Shares Held
25.8MCall Options Held
511KPut Options Held
100-
Black Rock Inc. New York, NY3.04MShares$103 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.33MShares$78.6 Million0.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$53.3 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.54MShares$52 Million0.03% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.22MShares$41.1 Million0.44% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $888M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...